Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab
Clinical trial NCT04727164 · UNKNOWN
Trial details
- NCT number
- NCT04727164
- Sponsor
- Harbour BioMed (Guangzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-28
- Primary completion
- 2023-11-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.